Top Markets
Coin of the day
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
Rangering i aksjer #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
Aksjekurs
$0.49606484
Sist synkronisert: 2026-08-21
Markedsverdi
$88.47M
Endring (1 dag)
-1.58%
Endring (1 år)
-22.51%
Land
TW
Handel Intech Biopharm Corporation (6461)

Kategori

EPS for Intech Biopharm Corporation (6461)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Intech Biopharm Corporation er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Intech Biopharm Corporation fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH